Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Management of severe hypercalcemia.

K D Davis¹, M F Attie

¹Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.

Critical Care Clinics

|January 1, 1991

Summary

Severe hypercalcemia, often caused by tumors, requires urgent treatment. This case study highlights managing volume depletion and using bone resorption inhibitors like plicamycin for rapid calcium reduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurofilament-light in former athletes: a potential biomarker of neurodegeneration and progression.

European journal of neurology·2020

Same author

Slow-5 dynamic functional connectivity reflects the capacity to sustain cognitive performance during pain.

NeuroImage·2017

Same author

Abnormal cortical activity in patients with temporomandibular disorder evoked by cognitive and emotional tasks.

Pain·2010

Same author

Stability of phantom limb phenomena after upper limb amputation: a longitudinal study.

Neuroscience·2008

Same author

Cortical thinning in IBS: implications for homeostatic, attention, and pain processing.

Neurology·2007

Same author

Intraoperative recording of the very fast oscillatory activities evoked by median nerve stimulation in the human thalamus.

Supplements to Clinical neurophysiology·2006

Area of Science:

Nephrology
Endocrinology
Oncology

Background:

Severe hypercalcemia is a life-threatening condition, frequently linked to malignant tumors, advanced hyperparathyroidism, or vitamin D toxicity.
Malignancy-associated hypercalcemia presents with significant clinical challenges, including volume contraction, renal impairment, and neurological depression.

Observation:

The case study patient exhibited symptoms of dehydration and reduced renal function due to hypercalcemia.
Neurological symptoms, such as central nervous system depression, were noted, necessitating differential diagnosis including cerebral metastases.

Findings:

Intravenous fluid resuscitation is crucial for correcting volume depletion and promoting calcium excretion.
Bone resorption inhibitors (plicamycin, etidronate) and calcitonin are key in rapidly lowering serum calcium levels.
Treatment requires a multi-faceted approach, including supportive care and addressing the underlying cause, typically malignancy.

Implications:

Prompt and aggressive management of severe hypercalcemia is essential for preventing irreversible renal damage and improving patient outcomes.
Eradicating the underlying disease, particularly cancer, is paramount for long-term resolution of hypercalcemia.
Current treatments offer temporary control, emphasizing the need for definitive therapy against the primary pathology.

Related Experiment Videos